---
figid: PMC10473033__jcvp-82-201-g009
pmcid: PMC10473033
image_filename: jcvp-82-201-g009.jpg
figure_link: /pmc/articles/PMC10473033/figure/F9/
number: FIGURE 9
figure_title: ''
caption: Proposed schematic diagram for the mechanisms of sRLX against LPS-induced
  inflammation and fibrosis.
article_title: Serelaxin Inhibits Lipopolysaccharide-induced Inflammatory Response
  in Cardiac Fibroblasts by Activating Peroxisome Proliferator-activated Receptor-Î³
  and Suppressing the Nuclear Factor-Kappa B Signaling Pathway.
citation: Xueping Wu, et al. J Cardiovasc Pharmacol. 2023 Sep;82(3):201-211.
year: '2023'

doi: ''
journal_title: ''
journal_nlm_ta: ''
publisher_name: ''

keywords:
---
